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Parathyroid function in persistent hyperparathyroidism: Relationship
to gland size. The release of parathyroid hormone in experimental
animals is related inversely to the plasma calcium concentration. The
relevance, though, of these observations to the dynamics of parathyroid
function in normal and hyperparathyroid humans is uncertain. We
assessed the in vivo parathyroid hormone response to changes in
extracellular calcium in 8 normal subjects and 15 patients with persist-
ent hyperparathyroidism following renal transplantation. In 12 hyper-
parathyroid patients, the hormone response was related to their total
gland size measured at the time of their parathyroidectomy. Plasma-
ionized calcium, magnesium, and parathyroid hormone concentrations
were measured in the basal state and during a 2-hr infusion of EDTA (50
mg/kg), and a 4-hr calcium infusion (15 mg/kg). The parathyroid
function curves of both groups of subjects (P < 0.001) fit a log-linear
relationship. The slopes of the respective parathyroid function curves
were similar, although the hyperparathyroid curve was shifted to the
right (P < 0.0001). Gland size was not predicted by basal PTH levels;
however, it did correlate with changes in parathyroid hormone induced
by EDTA (P < 0.001) and calcium (P < 0.001). We conclude that the in
vivo sensitivity of hyperplastic glands to changes in plasma calcium is
maintained. The excessive secretion of immunoreactive parathyroid
hormone in chief cell hyperplasia primarily reflects total gland mass.
Our results indicate that the assessment of the dynamics of parathyroid
response, rather than measurements of static plasma parathyroid hor-
mone and calcium concentrations, should be further investigated as a
more rational application of radioimmunoassays in the evaluation of the
parathyroid axis.
Fonction parathyroidienne dans l'hyperparathyroidie persistante. Re.
lation avec Ia taille des glandes. Le relargage de l'hormone parathyrol-
dienne chez les animaux d'expérience est inversement relié a Ia
concentration plasmatique du calcium. Cependant, Ia signification de
ces observations dans Ia dynamique du fonctionnement parathyroidien
chez des sujets humains normaux et hyperparathyroidiens est incer-
tame. Nous avons étudid in vivo Ia réponse de l'hormone parathyrol-
dienne a des modifications du calcium extracellulaire chez 8 normaux
sujets et 15 malades ayant une hyperparathyroidie persistante après
transplantation rénale. Chez 12 malades hyperparathyroidiens, Ia ré-
ponse hormonale a été reliée au poids total de glandes mesuré lors de
leur parathyroIdectomie. Les concentrations plasmatiques de calcium
ionisé, de magnesium et d'hormone parathyroidienne ont été mesurées
a l'état basal, après une perfusion de 2 heures avec de I'EDTA (50 mg/
kg) et après une perfusion de 4 heures par du calcium (15 mg/kg). Les
courbes de fonction parathyroldienne des deux groupes de malades (P
< 0,001) suivaient une relation log-linéaire. Les pentes des fonctions
parathyroldiennes étaient identiques, bien que Ia courbe des hyperpar-
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athyroidiens soit déplacde vers Ia droite (P < 0,0001). La taille des
glandes n'était pas prévisible par les valeurs de PTH de base; cepen-
dant, elle dtait corrélée avec les modifications de l'hormone parathyroI-
dienne induites par I'EDTA (P < 0,001) et par le calcium (P < 0,001).
Nous concluons que Ia sensibilité in vivo des glandes hyperplasiques
aux modifications du calcium plasmatique est maintenue. La sécrétion
excessive d'hormone parathyroidienne immunoréactive lors de l'hyper-
plasie des cellules principales reflete essentiellement Ia masse glandu-
laire totale. Nos résultats indiquent que Ia dynamique de Ia reponse
parathyroidienne, plus que des mesures statiques des concentrations
d'hormone parathyroidienne et de calcium plasmatique, devrait être
étudiée plus avant en tant qu'application plus rationnelle des dosages
radioimmunologiques pour évaluer l'axe parathyroldien.
Experiments using radioimmunoassays for parathyroid hor-
mone [1—9] have provided direct evidence in animals for the
importance of the plasma ionized calcium (Ca) concentration
as the predominant determinant of glandular parathyroid hor-
mone biosynthesis and release. Early animal [3, 10] and in vitro
[11—15] experiments indicated that the secretion of parathyroid
hormone was inversely proportional to the extracellular calci-
um concentration. Subsequent studies [16—18], particularly
ones involving spontaneous and induced hypocalcemia in cows,
characterized the relationship by a sigmoid curve.
The relevance of these animal observations to human para-
thyroid function is uncertain since human studies comparable to
those carried out in bovine species [6, 15, 19—231 or in vitro
studies using parathyroid tissue from both animals and humans
[11, 15, 24—321 are not available. Specifically, the dynamics of
the in vivo response of normal subjects to changes in plasma
Ca + within the physiologic range and at both extremes of
plasma ionized calcium have not been studied systematically,
nor have such parathyroid function curves been reported in
patients with hyperparathyroidism (HPT). Previous human
studies have been limited to comparisons of absolute response
of parathyroid hormone concentrations to the infusion of either
calcium [33] or EDTA [34—37]. This study was designed to
characterize the in vivo response of normal (NL) and hyper-
plastic human parathyroid glands to both acute hypocalcemia
and hypercalcemia and to relate our biochemical data to direct
anatomical measurements of gland size.
Methods
Subjects. Eight normal volunteers (three males, five females;
mean age, 25 years) comprised the control population. They
were screened by history, physical examination, and routine
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laboratory tests for acute and chronic medical disorders and
any family history of endocrine diseases. None was taking
medication. Their mean (±sD) serum creatinine was 0.9 0.1
mg/dl.
Fifteen patients (seven males, eight females) were selected
from the Renal Transplant Clinic at the University of Oregon
Health Sciences Center. Selection was based upon biochemical
evidence of hyperparathyroidism, that is, persistent hypercal-
cemia (assessed by measurement of serum total and ionized
calcium concentrations), and inappropriately elevated serum
parathyroid hormone concentrations. These subjects had good
to excellent allograft function (mean, SD serum creatinine 1.3
0.3 mg/dl; range, 0.8 to 2.4 mg/dl) at the time of the study.
The mean interval post-transplant was 3.5 years (range, 1 to 7
years). All were taking prednisone (range, 7.5 to 15 mg/day)
plus either azathioprine or cyclophosphamide in varying dos-
ages. Three transplant recipients were taking propranolol,
which was discontinued 14 days before the studies in one. Two
patients were maintained on the drug. No patient was receiv-
ing vitamin D, oral phosphates, diuretics, cimetidine, or
sympathomimetics.
Protocols. The protocols were reviewed and approved by the
Committee on Human Experimentation of the University of
Oregon Health Sciences Center and the Advisory Committee of
the Clinical Research Center. All subjects were admitted to the
General Clinical Research Center and informed consent was
obtained. Their diet contained 2000 mg sodium (87 mEq), 2000
mg potassium (51 mEq), and 1000 mg calcium per day. A
general chemistry screen, complete blood count, urinalysis,
EKG, and chest x-ray were obtained on the day of admission.
The subjects received, in random order, either a 2-hr infusion of
disodium EDTA or a 4-hr infusion of calcium gluconate. All
infusions were initiated between 10 and 11 A.M. with the
subjects in a supine position; the subjects had fasted since the
previous evening. For the infusions, a small gauge, indwelling
needle was placed into a superficial vein of the forearm. All
blood samples were withdrawn from a vein of the contralateral
extremity through a second indwelling needle. Vital signs were
monitored every 15 mm during the infusions and at frequent
intervals postinfusion.
All of the eight normal and 15 HPT subjects received the
calcium infusion. Calcium was administered as the gluconate
salt at a dose of 13 to 15 mg of calcium per kilogram of body
weight. The calcium was placed in 5% dextrose and water (total
volume, 1 liter) and infused over 4 hr. Venous blood samples
were obtained immediately before (time, 0 mm) and at 30, 120,
and 240 mm during the infusion. Seven of the normal subjects
and 12 of the HPT patients were administered disodium EDTA
at a dose of 50 mg/kg which was placed in 1 liter (total volume)
of 5% dextrose and water. The EDTA was infused over 2 hr.
Venous blood samples were collected at time 0 and at 15, 60,
and 120 mm during the infusion. One to two milliliters of 2%
xylocaine were injected around the vein at the site of the
infusion needle. Acetaminophen, 600 mg, was given to several
subjects to control local discomfort from the EDTA. The
infusion rates were held constant by an infusion pump. At all
sampling intervals, blood was withdrawn for determination
of serum Ca, magnesium, and parathyroid hormone
concentrations.
On two additional days (either day 2, 4, 6, or 8) between 10
and 11 A.M., venous blood samples were withdrawn from the
forearm vein. These samples served as additional baseline data
for each subject for each of the parameters measured during the
infusions. A minimum of 48 hr separated either the infusions
and/or the baseline samples obtained in each subject. All of the
subjects tolerated the infusions without complications.
Parathyroid gland measurements. Twelve HPT transplant
recipients underwent surgical exploration of the neck. Six of
these individuals were among the HPT subjects originally
studied in the Clinical Research Center protocol. The other six
surgical candidates (three males, three females) had also been
followed in the Transplant Clinic. Their mean SD serum
creatinine was 1.2 0.2 mg/dl (range, 0.8 to 1.7 mg/dl) and their
mean time after transplantation was identical to that of the first
group (3.5 years). All six received an EDTA infusion, and three
of them also received a calcium infusion following identical
protocols, as outlined above with the exception that immunore-
active PTH was measured in only one assay (anti-PTH-l). All
12 of the HPT subjects were referred for total parathyroidecto-
my because of clinical complications (neuropsychiatric disor-
ders, metabolic bone disease, vascular calcifications) of hyper-
parathyroidism or persistent, severe hypercalcemia. (Ca >
2.8 mEq/liter or total calcium> 12.0 mg/dl). The mean time for
all the surgical patients between the infusions and surgery was 7
weeks.
At the time of surgery, a careful dissection of the neck and
upper mediastinum was performed; all suspected parathyroid
tissue was identified and excised. Immediately after excision
each specimen was trimmed of fat and measured in three
dimensions before either being placed in preservative or im-
planted in the nondominant forearm. Confirmation of each
specimen's cell type was made by both frozen section ex-
amination and by light microscopic examination of the perma-
nent pathologic sections. One trained observer made and re-
corded all the measurements in these 12 patients. Parathyroid
gland volume was calculated using the three dimensional
measurements.
Analytical methods. Venous blood samples were collected in
10 ml glass vacutainers, chilled immediately and, within 30 mm,
centrifuged at 4° C. The serum was separated, placed in plastic
vials and stored at —20° C. Magnesium concentrations were
determined by atomic absorption spectrophotometry. Cail
was measured directly (NL values 2.14 0.08 mEq/liter,
mean SD) (Applied Medical Technologies, Palo Alto, Califor-
nia) [38, 391. All analyses for magnesium and Ca were
performed in duplicate, and a mean value was reported.
In the initial studies of the HPT subject, immunoreactive
parathyroid hormone was determined in two different assays.
Both assays used antibovine PTH antisera raised in guinea pigs
by repeated subcutaneous immunization with highly purified
bovine PTH as well as trichloroacetic acid extract from bovine
parathyroid gland (Inolex, Biomedical Division, Wilson Phar-
maceutical and Chemical Corp., Glenwood, Illinois). Complete
immunochemical characterization of the two antisera was es-
tablished from tracer displacement studies by highly purified
preparations of bovine and human PTH 1-84, natural bovine 53-
84, synthetic human and bovine 1-34, synthetic human 53-84,
44-68, bovine 28-48 (all fragments kindly supplied by Dr. John
T. Potts, Jr., Department of Medicine, Massachusetts General
Hospital, Boston, Massachusetts), as well as selective clinically
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diagnosed hyperparathyroid sera and parathyroid gland
effluent.
Antiserum GP101 proved to contain two distinct populations
of antibodies in about equal concentration and of approximately
equal affinity for the amino- and carboxyl-terminal sequence of
human and bovine PTH (N/C, biterminal antiserum). Antiserum
Anti-PTH-l (C-antiserum) almost exclusively interacts with the
carboxyl 53-84 region of bovine and human PTH; more than 75
and 90% of the tracer is displaced by natural bovine 53-84 and
synthetic human 53-84, respectively. Less than 5% of the tracer
is displaced competitively by 10,000-fold molar excess of syn-
thetic bovine or human PTH 1-34. Cross reaction of human
PTH 1-84 with bovine PTH 1-84 is about 50% for anti-PTH-1
and 30% for the biterminal antiserum GPIOI. When, however,
immunoreactive PTH present in primary and secondary hyper-
parathyroid serum is analyzed, a three- to fourfold higher cross
reaction is exerted by anti-PTH-1 than by the biterminal
antiserum.
Highly purified bovine PTH 1-84 was labelled with Iodine-125
by a modified method of Greenwood, Hunter, and Glover [40]
which uses only a 17-fold molar excess of chloramine-T over
the hormone. The same monoiodinated tracer with an immuno-
reactivity of at least 85% was used in both assays.
Pooled human hyperparathyroid serum was used as standard
in the biterminal (N/C) assay, while both the human hyperpara-
thyroid pooled serum and highly purified bovine PTH 1-84 were
used as standards in the carboxyl-terminal specific (C) assay.
Comparison of immunochemical potencies of these two stan-
dards in the C-assay has shown that 1 ng of bovine PTH 1-84 is
equal to approximately 50 tl of the human hyperparathyroid
serum pool.
Immunoreactive PTH of previously unthawed sera was deter-
mined at 40 C in a 3-day nonequilibrium assay based on the
biterminal antiserum and a 3-day equilibrium assay using the C-
terminal specific antiserum. Separation of bound from free
tracer was accomplished with a second antibody (goat anti-
guinea pig gamma globulin, Antibodies Incorporated, Davis,
California). All sera from each subject's infusion were analyzed
in duplicates in the same assay.
The interassay coefficients of variation for the biterminal
assay were 14.5, 12.0, and 10.7% for poois with a mean PTH
concentration of 50, 103, and 742 ilEq/ml, respectively, and 6.2
or 13.9% for serum pools with a mean PTH concentration of 1.5
and 27.6 ng equivalent bovine PTH 1-84/mi, respectively, for
the N/C-assay. Twenty-five microliter equivalents per milliliter
is the lower limit of detection for this assay.
The interassay coefficient of variation for the biterminal
assay was 10.6% and 9,2% for a serum pool of 103 and 742
1dEq/ml, respectively, and 8.1 or 16.3% for a serum pool of 2.4
or 18.3 ng equivalent bPTH 1-84/mi, respectively, for the C-
assay. Twenty microliter equivalents per milliliter is the lower
limit of detection for this assay.
ANOVA, t-statistics and linear regression analyses were
used in the analysis of the data. In addition, the analysis of the
PTH concentrations by the interval calcium values utilized the
method described by Blum et a! [6, 71.
Results
EDTA infusions. Figures IA and B portray the effect on the
serum magnesium, ionized calcium and parathyroid hormone
concentrations (as measured by the two assays) in the NL and
HPT subjects, respectively, during the EDTA infusion. Magne-
sium was unchanged in both groups. Ca levels declined
beginning at 15 mm (P < 0.001) in both NL and HPT and
continued to decrease throughout the 120 mm (P < 0.001). The
mean decrease in Ca [0.45 mEq/liter (NL) versus 0.96 mEq/
liter (HPT)] was significantly different (P < 0.001) for the two
groups. PTHGPIOI was increased significantly in both groups (P
< 0.001). There was no further increase in the NL's PTH
concentration after 60 mm. The mean maximal change in
PTHGPOI of 54 dEq/ml (NL) versus 529 dEq (HPT) was
significantly different (P < 0.001). While PTH, as measured by
antiserum, anti-PTH-1 progressively increased (P < 0.001) in
both NL and HPT, the rise for both the NL and HPT subjects
was less than that detected by the biterminal assay (GPIO1).
The NL's maximal change in PTHantIPTHI (0.27 ng/ml) was
significantly less (P < 0.001) than that detected in the HPT (4.24
ng/ml) subjects.
Calcium infusions. Figures 2A (NL) and B (HPT) depict the
response of the same four parameters (Mg, Ca , PTHGPJOI,
PTH0fltjPTH1) to the calcium infusions. Serum magnesium was
unaffected in the HPT subjects while the NL subjects experi-
enced a transient decline at 120 mm. Ca increased progres-
sively in both groups (P < 0.001). The average maximal
increase in Ca for the NL's (0.76 mEq/liter) was not statisti-
cally different from that achieved in the HPT patients (1,14
mEq/liter), as there was a wide variation in the transplant
patients' response. PTH measured in assay GP1OI progressive-
ly (P < 0.001) declined in both NL and HPTH subjects. Both
groups experienced an immediate, significant (P < 0.01) decline
in PTHp1i during the first 30 mm followed by a plateau and
then a later, further fall in PTH that was also significant (P <
0.01). The mean NL subjects' decline in PTHGPIOI (19 ptEq/ml)
was less (P < 0.001) than the HPT subjects' (72 pJEq/ml).
PTHantipTHi was unchanged in the NL while the HPT patients
demonstrated a progressive decrease (P < 0.001). As with the
EDTA infusions, the antiserum GPIOI again proved more
sensitive than anti-PTH-l to the changes in the immunoreactive
PTH that occurred.
Parathyroid function curves. Figure 3A shows the concentra-
tion of PTH as measured in both assays grouped according to
intervals of Ca and then plotted against those mean values of
serum Ca Beside the infusion data, the additional baseline
observations are included in this graph. This transformation of
the data is identical to that used by Blum, Mayer, and Potts [6],
Blum et al [7], Mayer and Hurst [22, 23], and Keaton et al [21] in
their reports of similar studies in bovine species. The acute
response of the normal parathyroid gland to changes in serum
Ca is nonlinear. Because of the greater sensitivity of the
antiserum with both NH2- and COOH-terminal antigenic speci-
ficity, the nonlinear relationship between serum PTH and Ca
is more apparent with the GP1O1 antiserum.
The data for the HPT subjects analyzed in the same fashion is
shown in Figure 3B. As noted above, the HPT patients experi-
enced a greater degree of induced hypercalcemia and hypocal-
cemia. Consequently, 14 intervals of calcium are plotted. A
nonlinear, relationship between serum PTH and Ca is evi-
dent, and a plateau value for PTH is suggested. As with the NL
subjects' parathyroid function curves, the assay with NH2- and
COOH-terminal specificity better defined the nonlinear nature
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Fig. 1. A Two-hour EDTA infusion (50 mg/kg) results in seven normal
subjects. B Two-hour EDTA infusion (50 mg/kg) results in 12 hyperpar-
athyroid renal transplant recipients. Internal values (mean 5EM) for
Mg, Ca, PTHGPIOI (N/C), and PTHanIIPTHI (C). Significance of
changes relative to previous value: ap < 0.05, b < 0.02, P < oØ, p
< 0.005, 'P <0.001.
of the relationship. In the HPT subjects, the COOH-terminal
specific PTH assay also clearly demonstrated a log-linear
relationship. For both the NL and FIPTpatients, the two assays
provided similar values for immunologically-reactive PTITI with-
in the normal and hypercalcemic range.
For both our normal (r = — .68) and hyperparathyroid trans-
plant subjects (r = —.54), their serum Ca was inversely
correlated (P < 0.001) with the natural logarithm of their
simultaneously measured PTH level (PTHGpIffl). It is notewor-
thy that the slopes of the regression formulae relating the log
PTH and Ca were similar(NL = —0.59 versus HPT =
—0.6);
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Fig. 2. A Four-hour Ca infusion (15 mg/kg) results in eight normal
subjects. B Four-hour Ca infusion (15 mg/kg) results in 14 hyper-
parathyroid renal transplant recipients. Internal value (mean sEM)
for Mg, Ca, PTHGPIOI (N/C), and PTHa,,tj.rHI (C). Significance of
changes relative to previous value: ap < 0.05, b < 0.02, cp < 0.01, d
<0.005, "P < 0.001.
however, the Yintercepts(NL = 5.56versusHPT = 7.1l)differ
(P < 0.001). This is indicative of the HPT curve being shifted to
the right, that is, at any level of serum Ca the HPT patients'
PTH concentrations are significantly greater.
Parathyroid hormone response and gland size. Twelve HPT
transplant recipients underwent total parathyroidectomy with
forearm reimplantation. The correlation (r = 0.5055) of basal
PTH values (c assay) with gland volume was not signifi-
cant. The absolute change () in the immunoreactive PTH
(LPTH2 hr EDTA) that occurred between time 0 mm and the end
(120 mm) of the EDTA infusion is graphed as a function of gland
volume in Figure 4. The PTH2 hr EDTA was correlated signifi-
cantly (r = 0.98, P < 0.0001) with the gland volume. The
0 30 120 240
Time, mm
concentration of PTH at the end of the EDTA infusion also
correlated with the gland volume (r = 0.9663, P < 0.0001).
Figure 5 depicts the relationship between the absolute in
PTH levels induced by the Ca infusion and the gland volume.
The degree of PTH suppression achieved was correlated closely
with gland volume (r = 0.99, P < 0.0001). In contrast to the
stimulation of the gland, suppression of PTH occurred as a
nonlinear function of gland volume. The maximally suppressed
(4 hr) value of PTH also correlated (r = 0.93, P < 0.0001) well
with the gland volume.
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Fig. 3. A Relationship between PTH0101 (• N/C-assay) or PTHantjJHI(Cc-assay) and plasma Ca in eight normal subjects. PTH concentra-
tion is expressed as mean SEM values for 0.125 or 0.25 mEq/liter
increments of plasma Numbers above the bars designate the
numbers of samples. Numbers were identical for the two assays. B
Relationship between PTHGPIOI (• N/C-assay) or PTHatTHI (0 c-
assay) and plasma Ca + in 14 hyperparathyroid renal transplant
recipients. PTH concentrations are expressed as mean SEM values for
0.125 or 0.25 mEq/liter increments of plasma Ca Numbers above
and below the bars designate the numbers of samples at each interval in
each assay.
Discussion
Previous animal experiments [3, 101 and in vitro studies of
parathyroid gland explants from both animals and humans [11—
15] demonstrated that regulation of parathyroid hormone re-
lease is inversely proportional to the plasma Ca concentra-
tion. Blum, Mayer, and Potts [6] characterized the acute in vivo
bovine parathyroid hormone response to alterations in plasma
Ca levels as a sigmoid curve. Derivative experiments by
these investigators in the same bovine model confirmed that the
acute changes in immunoreactive PTH detectable in venous
samples were a valid reflection of actual secretory rates of the
gland [221. Data presented in several in vitro studies [15, 24,321
using human parathyroid tissue have also suggested a nonlinear
response of glandular tissue to changes in extracellular Ca
Recently, the in vitro response of human parathyroid tissue to
acute hypercalcemia has been correlated with the in vivo
response as measured by PTH levels in peripheral venous
samples 116] and nephrogenous cyclic adenosine monophos-
phate excretion [9, 25].
The inverse, curvilinear relationships described in this study
are remarkably similar to the previously defined sigmoid para-
thyroid gland function curves reported in experimental animal
models [6, 2 1—231. Numerous human and in vitro [16, 17, 24—26,
28] experiments have demonstrated that release of hormone by
hyperplastic glands will decrease with acute hypercalcemia.
The responsiveness to acute hypocalcemia, though, in these
states has not been as well defined. In the current study, the
sensitivity of HPT glands to both acute hypocalcemia and
hypercalcemia is well preserved and demonstrates response
characteristics that parallel those of NL subjects. If the regula-
tion of hyperplastic glands by plasma Ca + was markedly
impaired, the slope of the two response curves should have
been significantly different. This was not the case. The parathy-
roid function curve of the transplant recipients are simply
shifted to the right. Keaton et al [21] noted a similar effect in the
neonatal calf, an experimental model of parathyroid hyperpla-
sia. These findings indicate that the sensitivity of the hyperplas-
tic gland to acute changes in plasma calcium in vivo is well
maintained.
The high plasma concentrations of immunoreactive PTH,
detectable despite extreme hypercalcemia in the HPT patients,
probably reflect obligatory secretion of carboxyl-terminal hor-
mone fragments by the increased mass of parathyroid tissue, as
suggested by other investigators [28—30, 41, 42]. Proportionally,
secretion of these fragments increases as extracellular calcium
rises. The secretion of peptide fragments is believed to be a
normal response of the parathyroid cells rather than a primary
defect in the glandular tissue's feedback regulation by calcium,
as suggested by earlier investigations. Although impaired clear-
ance by the transplanted kidney of the carboxy-terminal frag-
ments could contribute to the excessive levels of immunoreac-
tive PTH, the good to excellent graft function of our subjects
makes this less likely. Impaired renal clearance would also be
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Fig. 4. Relationship of total parathyroid gland size (cm3) of ten HPT
patients measured at surgery and the maximal (2-hr) change (A) in
PTH induced by the EDTA infusion. The C-terminal (anti-PTH-I) assay
utilizing the pooled hyperparathyroid serum is portrayed,
expected to change the slope of the function curve in patients
with parathyroid hyperplasia, which was not the situation.
Hyperparathyroidism after renal transplantation has been
considered the prototype of diffuse hyperplasia of the parathy-
roid glands. Persistent HPT has been thought by some authors
to represent a primary failure of feedback inhibition by Ca
that is, gland autonomy. The fact that gland responsiveness [16,
17, 24—26, 28, 33, 35] and sensitivity to changes in plasma
calcium is retained by hyperplastic parathyroid glands implies
that an increased total number of parathyroid cells, and not an
obligate change in gland sensitivity, is the major defect in post-
transplant parathyroid hyperplasia. The recent report of Brown
et a! [43] concluded that a similar situation existed in parathy-
roid glands from uremic subjects. Those studies were per-
formed in vitro in a dispersed cell system. The close correlation
of total gland size with the in vivo secretory response
(LPTH2 hr EDTA) of the hyperplastic gland is also consistent
with that hypothesis.
In addition, our findings demonstrate the possible utility of
measuring the maximal acute secretory capacity of the parathy-
roid glands as an index of functioning gland mass. Additional
clinical investigation would appear to be warranted based upon
these initial observations. Such an index would provide a
parameter that could be determined periodically to evaluate the
progress or regression of parathyroid hyperplasia. The advan-
tage of assessing the dynamics of parathyroid function rather
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Fig. 5. Relationship of total parathyroid gland size (cm3) of nine HPT
subjects measured at surgery and the maximal (4-hr) change (A) in
PTH induced by the Ca infusion. The C-terminal (anti-PTH-l) assay
utilizing the pooled hyperparathyroid serum is portrayed.
than measurement of only static basal parameters is further
evident from the close correlation of the suppression of para-
thyroid function (LPTH4 hr Ca f) and the total gland volume.
The hypothesis that "stimulated" parathyroid hormone lev-
els may provide a better assessment of the human parathyroid
gland-calcium axis is consistent with the parathyroid gland
ultrastructural studies of Altenahr et al [9]. They noted that
basal immunoreactivity of PTH correlated less well (r + 0.68)
with gland weight than with a morphometric index (r + 0.95)
which included gland weight and estimations of percent volume
of parathyroid cells filled with mitochondria, secretory gran-
ules, golgi apparati, and glycogen. Ultrastructural analysis was
done by electromicroscopy of surgical specimens from patients
with "chief-cell adenomas." This study was limited by the
necessity to estimate total gland weight, as total parathyroidec-
tomies were not done, Even with that limitation, their findings
also demonstrate the ultimate importance of determining the
secretory or functional capacity of the parathyroid glands to
predict accurately the presence and magnitude of parathyroid
gland hyperlunction.
In conclusion, we have demonstrated that the in vivo re-
sponse curve of normal human parathyroid glands to acute
changes in plasma calcium is nonlinear. Renal transplant recipi-
ents with persistent parathyroid hyperplasia exhibit a similar
parathyroid function curve, although it is shifted to the right,
principally due to increased gland mass. Sensitivity of these
PTH gland function and mass 669
hyperplastic parathyroid glands to changes in plasma Ca
concentration appears to be preserved. Because of the hetero-
geneous nature of circulating immunoreactive PTH, it is often
difficult to predict accurately the presence of gland dysfunction
by radioimmunoassay of basal PTH. Our results suggest that
assessment of parathyroid gland functional or secretory capaci-
ty by perturbatory maneuvers may provide a more reliable
discriminatory index of parathyroid gland mass in hyperpara-
thyroidism. Future clinical investigations are required to deter-
mine whether or not this represents a more rational application
of the radioimmunoassay of PTITI, in the evaluation of the
parathyroid g1and-Ca axis.
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